Apollo Hospitals Enterprise Limited is a Pharmaceuticals company listed on the National Stock Exchange (NSE) with a market capitalisation of ₹1.23 lakh crore. The company reports ROE of 22.5%, a net profit margin of 8.1%. Revenue grew +20.8% year-over-year. Promoter holding stands at 28.4%, with FII participation at 50.6%.
Buying pressure is building (RSI/MACD momentum confirmed). Trading near its strongest price of the year (within 5% of 52-week high). Company earns strong returns on shareholder money (ROE 22.5% — above 15% benchmark). A trend-following indicator is on the bullish side (SuperTrend signal: buy). The whole industry is moving up together (sector — most peers above EMA20). The uptrend is visible even on the weekly chart (longer-term trend confirmed). Price just broke to a 20-day high after a quiet period (tight consolidation breakout — high probability setup). Short-term oscillator is overheated — entering now means chasing (StochRSI above 80, late entry risk). Above-average delivery percentage suggests real buying, not just speculation (delivery 59%). Both short and medium-term trend lines are pointing upward — the trend has momentum (rising EMA20 + EMA50). Foreign institutions have been net buyers for 4 consecutive days — sustained institutional demand (✅ FII buying streak). Approaching its key breakout zone — watch for a volume-backed close above resistance to confirm entry.
Apollo Hospitals Enterprise Limited scores 85/100 (High Conviction Research Signal). The strongest signals are Momentum (13/100) and Trend (11/100). The weakest dimension is Institutional Activity (0/100), which warrants monitoring. This reflects JaySense quantitative research scoring only — not investment advice. Consult a SEBI Registered Investment Adviser before making any investment decision.
| Stock | Score | Signal |
|---|---|---|
|
AUROPHARMA
Aurobindo Pharma Limited
|
82 | High Conviction |
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
72 | High Conviction |
|
CIPLA
Cipla Limited
|
72 | High Conviction |
|
DIVISLAB
Divi's Laboratories Limited
|
70 | High Conviction |
|
GLENMARK
Glenmark Pharmaceuticals Limited
|
64 | Positive Setup |